000			02001 a2200625 4500
005			20250516124035.0
264		0	_c20130220
008			201302s 0 0 eng d
022			_a1769-6917
024	7		_a10.1684/bdc.2012.1672 _2doi
040			_aNLM _beng _cNLM
100	1		_aVanhuyse, Marie
245	0	0	_aDo anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? _h[electronic resource]
260			_bBulletin du cancer _cDec 2012
300			_a100-6 p. _bdigital
500			_aPublication Type: Evaluation Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlkaline Phosphatase _xblood
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aBenzenesulfonates _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aBrain Neoplasms _xblood
650	0	4	_aCancer Care Facilities
650	0	4	_aCarcinoma, Renal Cell _xblood
650	0	4	_aEverolimus
650	0	4	_aFemale
650	0	4	_aFrance
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aKidney Neoplasms _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds
650	0	4	_aProportional Hazards Models
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSirolimus _xanalogs & derivatives
650	0	4	_aSorafenib
650	0	4	_aSunitinib
650	0	4	_aTreatment Outcome
700	1		_aPenel, Nicolas
700	1		_aCaty, Armelle
700	1		_aFumagalli, Ingrid
700	1		_aAlt, Marie
700	1		_aZini, Laurent
700	1		_aAdenis, Antoine
773	0		_tBulletin du cancer _gvol. 99 _gno. 12 _gp. 100-6
856	4	0	_uhttps://doi.org/10.1684/bdc.2012.1672 _zAvailable from publisher's website
999			_c22327622 _d22327622